Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

Cardiogenic shock (CS) remains the most common cause of death in patients admitted with
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …

Background The outcome of cardiogenic shock complicating myocardial infarction has not
appreciably changed in the last 30 years despite the development of various percutaneous …

Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state
of end-organ hypoperfusion that is frequently associated with multisystem organ failure …

Background: Cardiogenic shock (CS) is a multifactorial, hemodynamically complex
syndrome associated with high mortality. Despite advances in reperfusion and mechanical …

Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a widely
used form of mechanical circulatory support in patients with refractory cardiogenic shock. A …

Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Background Clinical investigations of shock in cardiac intensive care units (CICUs) have
primarily focused on acute myocardial infarction (AMI) complicated by cardiogenic shock …

Heart failure (HF) complicating myocardial infarction (MI) is common and may be present at
admission or develop during the hospitalization. Among patients with MI, there is a strong …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …